the next time you reply to one of my posts please bother to read it first. first of all we discuss production costs and not costs for patients .. Secondly; I have never claimed that there are no cancer drugs on the market it is more expensive to produce than DCVax, if so I would had written that it IS the most expensive and not that it is among the most expensive to produce.
just to then explain why, i among other things, bring it up, is that one of the reasons why BP havn’t been particularly interested in personal immunotherapy precisely is the cost of production compared to "mass produced" products .. even though everyone knows it is the future .. but again thanks for your data they are just bad and wrong in relation to the discussion. You and bio
Market Data 
Markets 
AI
